Sustained effect of LACTIN-V (Lactobacillus crispatus CTV-05) on genital immunology following standard bacterial vaginosis treatment: results from a randomised, placebo-controlled trial

BACKGROUND: Bacterial vaginosis might increase HIV risk by eliciting genital inflammation and epithelial barrier disruption, whereas vaginal Lactobacillus crispatus is associated with immune quiescence and HIV protection. We investigated the effect of a live biotherapeutic containing L crispatus CTV...

Descripción completa

Detalles Bibliográficos
Autores principales: Armstrong, Eric, Hemmerling, Anke, Miller, Steve, Burke, Kerianne E, Newmann, Sara J, Morris, Sheldon R, Reno, Hilary, Huibner, Sanja, Kulikova, Maria, Nagelkerke, Nico, Coburn, Bryan, Cohen, Craig R, Kaul, Rupert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188188/
https://www.ncbi.nlm.nih.gov/pubmed/35659905
http://dx.doi.org/10.1016/S2666-5247(22)00043-X

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188188/
https://www.ncbi.nlm.nih.gov/pubmed/35659905
http://dx.doi.org/10.1016/S2666-5247(22)00043-X

Ejemplares similares